|
- Collaborative research on AI-based diagnosis of multiple sclerosis, Building a clinical trial dataset
- Leveraging large-scale, multi-center brain MRI datasets to detect key lesion biomarkers
SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it will conduct a joint research collaboration with the Vall d'Hebron Institut de Recerca (VHIR), the research institute of Vall d'Hebron University Hospital in Spain. The collaboration will focus on Neurophet AQUA MS, its quantitative imaging software for multiple sclerosis.
The joint study aims to develop and validate AI algorithms that detect multiple sclerosis lesions based on magnetic resonance imaging (MRI). To this end, both parties will secure high-quality, large-scale datasets related to multiple sclerosis and will accelerate the development of new technologies to be integrated into Neurophet AQUA MS.
Neurophet AQUA MS is a software module integrated into Neurophet AQUA, Neurophet's brain imaging analysis solution, and is designed to analyze brain images of patients with multiple sclerosis, a chronic and debilitating disease of the central nervous system. The product received FDA 510(k) Clearance in October 2024.
Multiple sclerosis is a chronic disease affecting the central nervous system, which comprises the brain, spinal cord, and optic nerves. It primarily occurs in young adults aged 20 to 40 and shows a higher prevalence in women. It is also more common among Caucasian populations in North America and Europe, while relatively less prevalent in Asian and Black populations. Considering these regional characteristics, Neurophet AQUA MS is expected to establish itself as a strategic product in the U.S. and European markets, where the prevalence of multiple sclerosis is high.
Under the collaboration, VHIR will provide de-identified brain MRI datasets from clinically diagnosed multiple sclerosis patients, along with expert-annotated ground truth lesion labels. Based on these datasets, Neurophet will develop and validate AI algorithms. In particular, the collaboration will focus on developing detection algorithms for the Central Vein Sign (CVS) and Paramagnetic Rim Lesions (PRL)—key imaging biomarkers emphasized in the latest diagnostic criteria—leveraging a large-scale dataset of over 1,000 patients.
Located in Barcelona, Spain, Vall d'Hebron University Hospital is the largest medical institution in Spain, integrating adult, pediatric, women's, and rehabilitation hospitals. It also played a leading role in establishing the 2024 Revised McDonald Criteria, the international standard for the diagnosis of multiple sclerosis.
Dr. Alex Rovira Cañellas, principal investigator of the Neuroradiology Research Group at VHIR, the hospital's research institute, is widely recognized as a world-leading neuroradiologist in the field of multiple sclerosis. Through this collaboration, Neurophet expects to leverage VHIR's world-class clinical data and expertise to further strengthen the clinical reliability of its AI technology.
Donghyeon Kim, Co-CEO of Neurophet, stated, "This collaboration with VHIR enables us to directly develop and validate Neurophet's AI-based multiple sclerosis analysis technology through a leading institution in Europe. Going forward, we plan to further strengthen the clinical reliability of our AI algorithms based on large-scale datasets."
About Neurophet
Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.
Major products include brain MRI analysis software "Neurophet AQUA", PET Image Quantitative Analysis Software "Neurophet SCALE PET", Brain imaging treatment planning software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB", Alzheimer's Disease treatment prescription and monitoring software "Neurophet AQUA AD" for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software "Neurophet AQUA MS".
Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.
- Collaborative research on AI-based diagnosis of multiple sclerosis, Building a clinical trial dataset
- Leveraging large-scale, multi-center brain MRI datasets to detect key lesion biomarkers
SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it will conduct a joint research collaboration with the Vall d'Hebron Institut de Recerca (VHIR), the research institute of Vall d'Hebron University Hospital in Spain. The collaboration will focus on Neurophet AQUA MS, its quantitative imaging software for multiple sclerosis.
The joint study aims to develop and validate AI algorithms that detect multiple sclerosis lesions based on magnetic resonance imaging (MRI). To this end, both parties will secure high-quality, large-scale datasets related to multiple sclerosis and will accelerate the development of new technologies to be integrated into Neurophet AQUA MS.
Neurophet AQUA MS is a software module integrated into Neurophet AQUA, Neurophet's brain imaging analysis solution, and is designed to analyze brain images of patients with multiple sclerosis, a chronic and debilitating disease of the central nervous system. The product received FDA 510(k) Clearance in October 2024.
Multiple sclerosis is a chronic disease affecting the central nervous system, which comprises the brain, spinal cord, and optic nerves. It primarily occurs in young adults aged 20 to 40 and shows a higher prevalence in women. It is also more common among Caucasian populations in North America and Europe, while relatively less prevalent in Asian and Black populations. Considering these regional characteristics, Neurophet AQUA MS is expected to establish itself as a strategic product in the U.S. and European markets, where the prevalence of multiple sclerosis is high.
Under the collaboration, VHIR will provide de-identified brain MRI datasets from clinically diagnosed multiple sclerosis patients, along with expert-annotated ground truth lesion labels. Based on these datasets, Neurophet will develop and validate AI algorithms. In particular, the collaboration will focus on developing detection algorithms for the Central Vein Sign (CVS) and Paramagnetic Rim Lesions (PRL)—key imaging biomarkers emphasized in the latest diagnostic criteria—leveraging a large-scale dataset of over 1,000 patients.
Located in Barcelona, Spain, Vall d'Hebron University Hospital is the largest medical institution in Spain, integrating adult, pediatric, women's, and rehabilitation hospitals. It also played a leading role in establishing the 2024 Revised McDonald Criteria, the international standard for the diagnosis of multiple sclerosis.
Dr. Alex Rovira Cañellas, principal investigator of the Neuroradiology Research Group at VHIR, the hospital's research institute, is widely recognized as a world-leading neuroradiologist in the field of multiple sclerosis. Through this collaboration, Neurophet expects to leverage VHIR's world-class clinical data and expertise to further strengthen the clinical reliability of its AI technology.
Donghyeon Kim, Co-CEO of Neurophet, stated, "This collaboration with VHIR enables us to directly develop and validate Neurophet's AI-based multiple sclerosis analysis technology through a leading institution in Europe. Going forward, we plan to further strengthen the clinical reliability of our AI algorithms based on large-scale datasets."
About Neurophet
Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.
Major products include brain MRI analysis software "Neurophet AQUA", PET Image Quantitative Analysis Software "Neurophet SCALE PET", Brain imaging treatment planning software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB", Alzheimer's Disease treatment prescription and monitoring software "Neurophet AQUA AD" for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software "Neurophet AQUA MS".
Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Neurophet Launches Joint Study with VHIR on 'Neurophet AQUA MS', Accelerating AI Algorithm Validation
ESR reimagines tech accessories as a seamless extension of personal style through its first themed collection
WILMINGTON, Del., May 26, 2026 /PRNewswire/ -- ESR, a global tech accessories brand trusted by over 130 million users worldwide, today unveils its Summer Collection, a playful yet refined lineup of iPhone 17 series cases and magnetic wallets. The collection introduces two distinctive series: Coastal Summer and Tropical Paradise, capturing the vibrancy of sun-drenched beaches and lush tropical escapes, that combine seasonal style with everyday convenience.
"Summer is all about moments that spark joy and self-expression," explains Elsie Chu, ESR Senior Director of Product Protection. "As tech becomes more integrated into everyday life, we believe it should seamlessly complement personal style while making everyday experiences easier. With our first specially designed collection, we wanted to capture the carefree spirit of the season, creating designs that are more than just accessories—they let you carry the energy of summer with you every day."
Summer Designs That Capture Coastal Light and Tropical Colors
Summer is about coastal escapes and tropical landscapes, and these vivid inspirations shape the two series. The Coastal Summer Series blends soft ocean-inspired tones with subtle starfish and seashell accents, echoing the lightness and ease of summer by the sea. The Tropical Paradise Series layers vivid florals and sun-saturated greens into patterns that carry the energy of a tropical summer.
Whether heading to a seaside getaway, dipping toes into the azure sea, or lounging poolside, the Summer Collection is designed to keep up with users' lifestyles. With ESR's MagSafe-ready accessories, users can effortlessly keep essentials protected while adding style and convenience, from snapping on a magnetic wallet to hands-free viewing on the go.
ESR's dedication extends beyond style and functionality, placing sustainability at the heart of the collection's packaging. Every box is 100% recyclable, reflecting ESR's commitment to responsible design. Floral and coastal pastel motifs across the presentation box further enhance the summer vibe, making for the perfect gift or even a personal treat
These playful, sun-kissed patterns come alive across ESR's iPhone cases and phone magnetic wallets, each designed to keep devices stylish, connected, and ready for summer adventures.
Product Highlights
- Summer Ready iPhone Cases
ESR brings playful summer style to its best-selling Classic Hybrid Magnetic Case Series. Vibrant, fade-resistant patterns are applied through high-quality printing, creating rich, tactile finishes that elevate the feel and summer look of the iPhone.
Built for effortless daily use, the series combines all-around protection with built-in magnets for secure MagSafe attachment. Select models also feature an integrated Stash Stand, enabling hands-free viewing and lens protection, perfect for capturing and enjoying summer moments anywhere. Compatible with iPhone 17, iPhone 17 Pro, and iPhone 17 Pro Max. Available on Amazon and the ESR Store now.
The seasonal makeover also extends to ESR's two iconic magnetic wallets. The Aura Clutch Magnetic Wallet is sleek yet spacious, securely holding up to 5 cards and 2 bills. It features powerful magnets, RFID-blocking protection to keep cards safe, and a built-in stand for a comfortable viewing angle. Available on Amazon and the ESR Store now.
For a minimalist alternative, the Classic Magnetic Wallet offers a more compact design with an easy-access cutout for quick card retrieval. Available on Amazon and the ESR Store now.
The Summer Collection reflects ESR's mission to make tech effortless and enjoyable. Every design, from the pastel serenity of Coastal Summer to the lively energy of Tropical Paradise, is a reminder that devices can be as expressive as users' lifestyles.
Availability
The full press kit can be found here. For more information about the Summer Collection, visit ESR's official website or Amazon store.
About ESR: Trusted for 17 Years
Founded in 2009, ESR is a global tech brand trusted by over 130 million users worldwide. We design tech accessories for smart devices to enhance everyday tech experiences. We're on a mission to make tech easier to use, developing products that seamlessly integrate into daily life, helping people live with greater ease and efficiency.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
ESR Launches Summer Collection: Where Seasonal Style Meets Everyday Tech
